Dr. Borghaei on the Efficacy of Nivolumab/Ipilimumab in STK11/KEAP1-Mutated NSCLC - OncLive
Hossein Borghaei, DO, MS, discusses the investigation of nivolumab plus ipilimumab and chemotherapy in patients with metastatic non–small cell lung cancer.
Hossein Borghaei, DO, MS, chief, Division of Thoracic Medical Oncology, professor, Department of Hematology/Oncology, co-director, Immune Monitoring Facility, Gloria and Edmund M. Dunn chair, Thoraci… [+1224 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
